Browse by Journals

JAMESON, Adam, FAISAL, Muhammad, FYLAN, Beth, BRISTOW, Greg C., SOHAL, Jaspreet, DALTON, Caroline, SAGOO, Gurdeep S., CARDNO, Alastair G. and MCLEAN, Samantha L. (2024). Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study. Journal of Psychopharmacology, 38 (4), 382-394. [Article]

REYNOLDS, Gavin (2024). The trace amine-associated receptor 1 agonists – non-dopaminergic antipsychotics or covert modulators of D2 receptors? Journal of Psychopharmacology, 38 (6), 503-506. [Article]

REYNOLDS, Gavin (2021). High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines? Journal of Psychopharmacology, 35 (9), 1030-1036. [Article]

IAMJAN, Sri-arun, THANOI, Samur, WATIKTINKORN, Paritat, REYNOLDS, Gavin and NUDMAMUD-THANOI, Sutisa (2018). Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis. Journal of Psychopharmacology, 32 (3), 309-315. [Article]

REYNOLDS, Gavin and MCGOWAN, Olga (2017). Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment. Journal of Psychopharmacology, 31 (11), 1430-1436. [Article]

VELTRI, Theresa, TAROYAN, Naira and OVERTON, Paul (2017). Nicotine enhances an auditory Event-Related Potential component which is inversely related to habituation. Journal of Psychopharmacology, 31 (7), 861-872. [Article]

COOPER, S. J., REYNOLDS, Gavin, BARNES, T., ENGLAND, E., HADDAD, P., HEALD, A., HOLT, R., LINGFORD-HUGHES, A., OSBORN, D., MCGOWAN, O., PATEL, M., PATON, C., REID, P., SHIERS, D. and SMITH, J. (2016). BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. Journal of Psychopharmacology, 30 (8), 717-748. [Article]

REYNOLDS, Gavin and NEILL, J. C (2016). Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine. Journal of Psychopharmacology, 30 (11), 1141-1144. [Article]

MONTEJO, Angel L, DEAKIN, JFW, GAILLARD, Raphael, HARMER, Catherine, MEYNIEL, Florent, JABOURIAN, Artin, GABRIEL, Cecilia, GRUGET, Celine, KLINGE, Corinna, MACFAYDEN, Christine, MILLIGAN, Holly, MULLINGS, Emma and GOODWIN, Guy (2015). Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. Journal of Psychopharmacology, 29 (10), 1119-1128. [Article]

MCKIBBEN, C. E., REYNOLDS, Gavin and JENKINS, T. A. (2014). Analysis of sociability and preference for social novelty in the acute and subchronic phencyclidine rat. Journal of Psychopharmacology, 28 (10), 955-963. [Article]

GREEN, Amy, KAUL, Arun, O’SHEA, Jacinta, SHARMA, Ekta, BENNETT, Lisa, MULLINGS, Emma L, MUNAFÒ, Marcus R., NUTT, David J., MELICHAR, Jan K. and DONALDSON, Lucy F. (2013). Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects. Journal of Psychopharmacology, 27 (3), 265-275. [Article]

CHAUDHRY, I. B., HALLAK, J., HUSAIN, N., MINHAS, F., STIRLING, J., RICHARDSON, Paul, DURSUN, S., DUNN, G. and DEAKIN, B. (2012). Minocycline benefits negative symptoms in early schizophrenia : a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. Journal of Psychopharmacology, 26 (9), 1185-1193. [Article]

BUNN, L. J, REYNOLDS, G. P, HALL, Adrian and DALTON, C. F (2005). Expression of 5-HT1A receptor mRNA is influenced by a common promoter region polymorphism. Journal of Psychopharmacology, 19 (5). [Article]